Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial - Kim, H-S; Kang, J; Hwang, D; HOST-REDUCE-POLYTECH-ACS investigators (Lancet, 2020)
(10257):